1. OP06 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry. (27th May 2021) Authors: Ungaro, R; Brenner, E; Agrawal, M; Gearry, R B; Kaplan, G G; Kissous-Hunt, M; Ng, S C; Rahier, J F; Reinisch, W; Steinwurz, F; Zhang, X; Lewis, J D; Kappelman, M D; Colombel, J F Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗